A study on siddha formulation Seenthil Sarkarai and Mathan Thailam in children for Padarthamarai(Dermatophytosis)

Clinical evaluation of Seenthil Sarkarai (Internal) and Mathan Thailam (External)for the management of Padarthamarai (Dermatophytosis) in children among out-patients attending of Ayothidass Pandithar Hospital,National Institute of Siddha - nil

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/04/084861

Enrollment

Registered

2025-04-16

Start date

Unknown

Completion date

Unknown

Last updated

2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B359- Dermatophytosis, unspecified

Interventions

Intervention1: SEENTHIL SARKARAI : SEENTHIL SARKARAI:Dose will be given according to weight of the child using Clark s rule. duration-48 days Intervention2: MATHAN THYLAM : MATHAN THYLAM:Required qua

Eligibility

Inclusion criteria

Inclusion criteria: Participants with clinical features of Padarthamarai (Dermatophytosis) NRS below 6 points(moderate) and CDLQI below 10 score(moderate)will be included.

Exclusion criteria

Exclusion criteria: Known cases of Skin diseases like contact dermatitis,vitiligo,psoriasis,atopic dermatitis. Other diseases or medications that might directly interfere in the study Diabetes mellitus -Type 1 in participants

Design outcomes

Primary

Measure	Time frame
Reduction of signs and symptoms of Dermatophytosis by NRS 0 point (no itching) and CDLQI 0 score (no effects on participant s life) after treatment is expected in study participants.Timepoint: Reduction of signs and symptoms of Dermatophytosis will be assessed after the period of 48 days	—

Secondary

Measure	Time frame
NilTimepoint: Nil	—

Countries

India

Contacts

Public ContactDr M Meenakshi Sundram

National Institute of Siddha

mmssiddha@rediffmail.com9444214582

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026